E Fund Management (HK)’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding FOLD
E Fund Management (HK)'s FOLD Position: Q2 2026 in Review
E Fund Management (HK) sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 1,005 shares — an estimated $14.5K sold.
E Fund Management (HK) first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $14.5K in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.
- E Fund Management (HK) reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- E Fund Management (HK) sold 1,005 Amicus Therapeutics shares in Q2 2026, an estimated $14.5K.
- E Fund Management (HK) first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
- E Fund Management (HK)'s Amicus Therapeutics position peaked at $14.5K in Q1 2026.
- 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.